YS

Yaswanth Saroj Chowdary Kumbha

Director DIN 08435053
DIN 08435053 First appointment Apr 2019
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Yaswanth Saroj Chowdary Kumbha

Data last updated:

Yaswanth Saroj Chowdary Kumbha was a Managing Director at Hymavati Laboratories Private Limited (from 2019) and Managing Director at Sriaan Laboratories Private Limited (from 2019).

DIN 08435053
First Appointment 26 Apr 2019
Oldest Company Age 7 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director13 Aug 20192019Strike Off
Sriaan Laboratories Private Limited U24239TG2019PTC132318
Managing Director26 Apr 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hymavati Laboratories Private Limited
Sriaan Laboratories Private Limited
Premium access

Shareholding and investment profile for Yaswanth Saroj Chowdary Kumbha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yaswanth Saroj Chowdary Kumbha

Yaswanth Saroj Chowdary Kumbha was first appointed on 26 Apr 2019 as Managing Director at Sriaan Laboratories Private Limited.

Yaswanth Saroj Chowdary Kumbha held 2 earlier board appointments: Hymavati Laboratories Private Limited (Managing Director, from 13 Aug 2019); Sriaan Laboratories Private Limited (Managing Director, from 26 Apr 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available